查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1627892

避孕药市场：预测（2025-2030 年）

Contraceptives Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

避孕药市场预计将以 6.48% 的复合年增长率成长，从 2025 年的 346.13 亿美元增长到 2030 年的 473.86 亿美元。

避孕是使用药物或设备来防止女性怀孕。其他方法通常被称为生育治疗或避孕。随着性传染病盛行率的上升，预计市场将继续成长。越来越多的女性正在寻求避孕药具和设备，尤其是年轻女性，随着教育程度的提高，她们开始使用避孕措施。

此外，青少年怀孕带来的健康风险、人们对现代避孕方法的认识不断提高以及越来越倾向于将口服避孕药作为避免意外怀孕的主要方法，这些都可能在未来几年推动市场成长。

避孕市场驱动因素

  • 人口控制需求上升推动避孕市场成长

各国政府为控制人口成长而采取的倡议，提高了都市区妇女的计划生育和避孕意识。此外，意外怀孕的增加也推动了口服避孕药的使用增加，尤其是在新兴市场。人口正以惊人的速度成长，尤其是在亚洲国家，影响了微观经济平衡。公共和私营部门正在共同努力遏制人口成长，性教育和避孕措施将在未来几年带来效益。预计这将在预测期内提高口服避孕药市场的收益。

避孕药市场的地理概况：

  • 预测期内，北美将呈现指数级成长。

北美市场的成长受到多种因素的推动，包括年轻人对性活动的倾向日益增加以及年轻人对生殖健康和避孕意识的提高。由于廉价非专利产品和设备的普及和使用，该地区的青少年对避孕的需求更大。在美国，公共资助的计划生育服务不断扩大，社会组织也加强了提高避孕机会的力道。最重要的是，两项由政府发起的帮助保险覆盖避孕措施的措施——《病患保护与平价医疗法案》和《第十条》——使这些产品更容易获得且更实惠。

为什么要购买这份报告？

  • 深入分析：深入了解主要地区和新兴地区的市场，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他子区隔。
  • 竞争格局：了解全球主要企业所采取的策略策略，并了解正确策略的潜在市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 各地区（包括细分市场和国家）的收益成长和预测分析
  • 公司概况（策略、产品、财务、主要发展等）

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第 5 章 避孕药市场（依产品划分）

  • 介绍
  • 药物
    • 避孕药
    • 注射避孕药
    • 局部避孕药
    • 装置
  • 保险套
    • 子宫内避孕器 (IUD)
    • 隔膜
    • 戒指
    • 其他的

第 6 章 避孕药市场通路

  • 介绍
  • 在线的
  • 离线

第 7 章 避孕市场（依年龄层）

  • 介绍
  • 15-24岁
  • 25-34岁
  • 35-44岁
  • 年龄 44 岁或以上

8. 避孕药市场（按地区）

  • 介绍
  • 北美洲
    • 按产品
    • 按分销管道
    • 按年龄段
    • 按国家
  • 南美洲
    • 按产品
    • 按分销管道
    • 按年龄段
    • 按国家
  • 欧洲
    • 按产品
    • 按分销管道
    • 按年龄段
    • 按国家
  • 中东和非洲
    • 按产品
    • 按分销管道
    • 按年龄段
    • 按国家
  • 亚太地区
    • 按产品
    • 按分销管道
    • 按年龄段
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Allergan plc（AbbVie）
  • ANSELL LTD.
  • Bayer AG
  • CooperSurgical Inc.
  • Merck & Co., Inc.,
  • Church & Dwight Co., Inc.
  • Veru Inc.
  • Mayer Laboratories, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Reckitt Benckiser Group plc
  • Mankind Pharma
  • Karex Berhad
  • Montage Laboratory
  • Pregna International Ltd.
简介目录
Product Code: KSI061613968

The contraceptive market is expected to grow at a CAGR of 6.48%, reaching a market size of US$47.386 billion in 2030 from US$34.613 billion in 2025.

Contraception is the application that prevents a woman from pregnancy through medications or devices. Other commonly known as fertility control and birth control. The market is expected to continue growing as the incidence of STDs rises. More women are seeking contraceptive medicines and devices, particularly among young women who are beginning to use contraception as they attain higher levels of education.

Furthermore, the health risks posed by teenage pregnancy, increased awareness regarding modern contraceptive methods, and a growing preference for oral contraceptives as the principal method to avoid unintended pregnancy are expected to drive market growth over the next few years.

Contraceptive Market Drivers

  • The growing need for population control is contributing to the contraceptive market growth

Government measures to control population growth in various countries have increased awareness of family planning and contraception among women in both rural and urban areas. Additionally, rising incidences of unintended pregnancies have led to increased utilization of oral contraceptives, especially in developed markets. Particularly in Asian countries, the population is expanding at an incredible rate, impacting the microeconomic balance. The public and private sectors are working together to control this growing population, which should benefit sex education and the use of contraceptives in the years to come. This is expected to drive the market revenue for oral contraceptives during the forecast period.

Contraceptive Market Geographical Outlook:

  • North America is witnessing exponential growth during the forecast period.

The market growth in North America includes the inclination of young people toward sexual activities and the high awareness of reproductive health and contraception among them regarding the matters. Teenagers in the regions need contraceptives more due to the introduction and spread of cheap generic products and devices. The expansion of publicly funded family planning services and the rise in social organization efforts in the US to increase access to contraception. Most importantly, the two government-aided initiatives where insurance covers contraceptive methods- the Affordable Care Act and Title X- have made these products accessible and affordable.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The contraceptive market is segmented and analyzed as follows:

By Product

  • Drugs
  • Contraceptive Pills
  • Injectable Contraceptives
  • Topical Contraceptives
  • Devices
  • Condoms
  • Intrauterine Devices (IUDs)
  • Diaphragms
  • Rings
  • Others

By Distribution Channel

  • Online
  • Offline

By Age Group

  • 15-24 years
  • 25-34 years
  • 35-44 years
  • Above 44 years

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CONTRACEPTIVE MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Drugs
    • 5.2.1. Contraceptive Pills
    • 5.2.2. Injectable Contraceptives
    • 5.2.3. Topical Contraceptives
    • 5.2.4. Devices
  • 5.3. Condoms
    • 5.3.1. Intrauterine Devices (IUDs)
    • 5.3.2. Diaphragms
    • 5.3.3. Rings
    • 5.3.4. Others

6. CONTRACEPTIVE MARKET BY DISTRIBUTIIN CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline

7. CONTRACEPTIVE MARKET BY AGE GROUP

  • 7.1. Introduction
  • 7.2. 15-24 years
  • 7.3. 25-34 years
  • 7.4. 35-44 years
  • 7.5. Above 44 years

8. CONTRACEPTIVE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Age Group
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Distribution Channel
    • 8.3.3. By Age Group
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Distribution Channel
    • 8.4.3. By Age Group
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Distribution Channel
    • 8.5.3. By Age Group
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Distribution Channel
    • 8.6.3. By Age Group
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Allergan plc (AbbVie)
  • 10.2. ANSELL LTD.
  • 10.3. Bayer AG
  • 10.4. CooperSurgical Inc.
  • 10.5. Merck & Co., Inc.,
  • 10.6. Church & Dwight Co., Inc.
  • 10.7. Veru Inc.
  • 10.8. Mayer Laboratories, Inc.
  • 10.9. Pfizer Inc.
  • 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.11. Reckitt Benckiser Group plc
  • 10.12. Mankind Pharma
  • 10.13. Karex Berhad
  • 10.14. Montage Laboratory
  • 10.15. Pregna International Ltd.